131 related articles for article (PubMed ID: 9875427)
1. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim HH; Kim YM; Han SK
Arch Pharm Res; 1998 Apr; 21(2):174-8. PubMed ID: 9875427
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim YM
J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM
Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Kim HH; Kong HS; Kim YM
Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine.
Kim H; Kim D; Choi D; Jeon H; Han J; Jung Y; Kong H; Kim YM
Drug Deliv; 2008 Jan; 15(1):37-42. PubMed ID: 18197522
[TBL] [Abstract][Full Text] [Related]
6. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim YM
J Pharm Sci; 2001 Nov; 90(11):1767-75. PubMed ID: 11745734
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
Li F; Wu G; Zheng H; Wang L; Zhao Z
Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
[TBL] [Abstract][Full Text] [Related]
11. N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis.
Kim H; Huh J; Jeon H; Choi D; Han J; Kim Y; Jung Y
J Pharm Sci; 2009 Jan; 98(1):159-68. PubMed ID: 18399548
[TBL] [Abstract][Full Text] [Related]
12. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of N-acyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
Lee JS; Jung YJ; Kim YM
J Pharm Sci; 2001 Nov; 90(11):1787-94. PubMed ID: 11745736
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS).
Cai QX; Zhu KJ; Chen D; Gao LP
Eur J Pharm Biopharm; 2003 Mar; 55(2):203-8. PubMed ID: 12637098
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.
Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM
J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092
[TBL] [Abstract][Full Text] [Related]
16. Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid.
Wiwattanapatapee R; Lomlim L; Saramunee K
J Control Release; 2003 Feb; 88(1):1-9. PubMed ID: 12586498
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D,L-glycine as a colon-specific prodrug of metronidazole.
Kim D; Hong S; Jung S; Jung Y; Kim YM
J Pharm Sci; 2009 Nov; 98(11):4161-9. PubMed ID: 19283770
[TBL] [Abstract][Full Text] [Related]
18. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.
Zou MJ; Cheng G; Okamoto H; Hao XH; An F; Cui FD; Danjo K
World J Gastroenterol; 2005 Dec; 11(47):7457-60. PubMed ID: 16437716
[TBL] [Abstract][Full Text] [Related]
19. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
Kim W; Nam J; Lee S; Jeong S; Jung Y
Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
